Core Viewpoint - The controversy surrounding Jinlongyu's peanut oil packaging, which claims to use a patented technology to remove aflatoxins, raises questions about the safety of the product and whether it implies the use of contaminated peanuts [1][3]. Group 1: Product Safety Concerns - A consumer raised concerns about Jinlongyu's peanut oil, questioning if the presence of "aflatoxin removal technology" suggests the peanuts used are contaminated [1]. - The official customer service of Jinlongyu clarified that the technology is used to ensure safety and does not imply the use of spoiled peanuts [1][3]. Group 2: Aflatoxin Information - Aflatoxins are toxic metabolites produced by fungi, classified as carcinogenic by the WHO, and can cause serious health issues if consumed in excess [3]. - The national food safety standard in China (GB 2761-2017) mandates that aflatoxin B₁ levels in food must not exceed 20μg/kg [5]. Group 3: Industry Practices - Other popular peanut oil brands do not prominently display "aflatoxin removal" on their packaging, indicating a potential marketing strategy by Jinlongyu to highlight safety [3]. - Experts suggest that the presence of aflatoxins in peanuts does not necessarily indicate spoilage, as they can occur during normal handling and storage processes [5][6]. - Many reputable oil brands utilize aflatoxin removal technologies, indicating that this practice is common in the industry [5].

Core Insights - UMeWorld Limited is expanding its flagship product, DAGola™, a clinically validated cooking oil that utilizes advanced enzymatic technology to produce high-purity diacylglycerol (DAG) [1][9] Product Overview - DAGola™ is formulated to meet the increasing global demand for healthier cooking oils, supporting fat metabolism and clinically proven to reduce triglycerides and lower uric acid levels, which are critical markers for metabolic syndrome, obesity, and gout [2][6] Market Expansion - DAGola™ is now available on Walmart Marketplace and Amazon, providing access to approximately 80% of online grocery shoppers in the U.S., which is expected to significantly boost U.S. revenue in Q4 2025 [3][7] - In China, UMeWorld is collaborating with leading national distributors to launch DAGola™ across online and offline channels, targeting the $25 billion edible oil market [5][8] Marketing Strategy - The company is initiating a targeted micro-influencer marketing program to enhance brand awareness and drive product trials, with plans to secure shelf space in mass-market retail chains [4][7] Scientific Validation - Clinical studies indicate that DAGola™ can reduce postprandial triglyceride formation by up to 80%, improve lipid metabolism, and support cardiovascular and metabolic health, positioning it favorably in the global edible oil market [6][9] Future Outlook - UMeWorld is well-positioned to execute its 2025 commercial roadmap, with expectations of significant contributions to top-line growth and global brand equity [7] - The company is also pursuing international expansion opportunities in Europe and Japan, aiming to leverage strategic partnerships and localized marketing initiatives [8]